Advertisement

European Journal of Dermatology

, Volume 28, Issue 5, pp 701–702 | Cite as

A case of possible chemical leukoderma secondary to usage of skin whitening agents

  • Maria Cho
  • Atsushi OtsukaEmail author
  • Hiroyuki Irie
  • Tatsuki Kataoka
  • Kenji Kabashima
Article
  • 2 Downloads

References

  1. 1.
    O’Reilly KE, Patel U, Chu J, Patel R, Machler BC. Chemical leukoderma. Dermatol Online J 2011; 17: 29.Google Scholar
  2. 2.
    Solano F, Briganti S, Picardo M, Ghanem G. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 2006; 19: 550–71.CrossRefGoogle Scholar
  3. 3.
    Katoulis AC, Alevizou A, Bozi E, et al. A randomized, double–blind, vehicle–controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. Clin Exp Dermatol 2009; 35: 473–6.CrossRefGoogle Scholar
  4. 4.
    Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147: 20–31.CrossRefGoogle Scholar
  5. 5.
    Bissett DL, Robinson LR, Raleigh PS, et al. Reduction in the appearance of facial hyperpigmentation by topical N–undecyl–10–enoyl–l–phenylalanine and its combination with niacinamide. J Cosmet Dermatol 2009; 8: 260–6.CrossRefGoogle Scholar
  6. 6.
    Yoshikawa M, Sumikawa Y, Hida T, et al. Clinical and epidemiological analysis in 149 cases of rhododendrol–induced leukoderma. J Dermatol 2017; 44: 582–7.CrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Maria Cho
    • 1
  • Atsushi Otsuka
    • 1
    Email author
  • Hiroyuki Irie
    • 1
  • Tatsuki Kataoka
    • 2
  • Kenji Kabashima
    • 1
  1. 1.Department of DermatologyKyoto University Graduate School of MedicineKyotoJapan
  2. 2.Department of Diagnostic PathologyKyoto University HospitalKyotoJapan

Personalised recommendations